Evidence map›Paper›PMID 26670283›Full record

ArticleTranslational psychiatry2015

Associations between the schizophrenia susceptibility gene ZNF804A and clinical outcomes in psychosis.

A Wickramasinghe, A D Tulloch, R D Hayes, C-K Chang, M Broadbent, M Di Forti, R M Murray, C Iyegbe, R Stewart

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Polymorphism in the ZNF804A Gene and Variation in DBiological psychiatry. Cognitive neuroscience and neuroimaging · 2023
    Article
  2. Review
  3. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2020
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

A WickramasingheInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
A D TullochInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
R D HayesInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
C-K ChangInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
M BroadbentSouth London and Maudsley NHS Foundation Trust, London, UK.
M Di FortiInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
R M MurrayInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
C IyegbeInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
R StewartInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
King's College London · GBSouth London and Maudsley NHS Foundation Trust · GB

Funding

Medical Research Council
6 · The paper itself

Abstract

We sought to test the hypothesis that the rs1344706 A allele will be associated with worse clinical outcome in first-episode psychosis. A data linkage was set up between a large systematic study of first-episode psychosis and an electronic health-record case register at the South London and Maudsley NHS Foundation Trust--a large provider of secondary mental-health care. A sample of 291 patients, who presented with a first psychotic episode (ICD10 diagnoses F20-29 or F30-33) and in whom the rs1344706 genotype had been assayed, were followed to examine the duration of mental-health in-patient care during the 2 years following first service contact, as a primary outcome. Secondary outcome measures were whether or not an in-patient episode occurred and the number of in-patient episodes during this period. A strong association was found between the number of rs1344706 A alleles and the cumulative duration of mental-health in-patient stay over the 2 years since initial presentation. In the 84.2% who experienced an in-patient episode during this period, the mean duration of admission was an additional 38 days for each A allele increment. Therefore, in addition to its potential role as a risk factor for psychosis, the ZNF804A rs1344706 A allele is associated with worse clinical outcome.

Indexed as

AdolescentAdultAgedFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansKruppel-Like Transcription FactorsLondonMaleMiddle AgedOutcome Assessment, Health CarePolymorphism, Single NucleotidePsychotic DisordersSchizophreniaYoung AdultKruppel-Like Transcription FactorsZNF804A protein, human

Identifiers

PMID26670283
PMCPMC5068593
OpenAlexW2221215953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.